CustomCustomCustomCustomCustomCustom

home2026-04-23T08:18:32+02:00

biomarkers for more stability in life

Our Mission:
RNA biomarkers for precision medicine

discovery_and_validation_of_microRNA_biomarkers

TAmiRNA is dedicated to supporting researchers and clinicians in RNA biomarker discovery, validation, and development. Our mission is to provide innovative diagnostic solutions that improve patient outcomes, with a focus on precision medicine and age-associated diseases.

TAmiRNA - stability for live

Our Expertise:
RNA signatures and diagnostics

mircoRNA_signatures

We specialize in biomarker discovery using cell-free RNAs, including microRNAs, mRNAs, and long non-coding RNAs (lncRNAs). By integrating RNA signatures with AI-driven analysis, we develop actionable diagnostic solutions that enhance disease detection and patient stratification.

TAmiRNA - stability for live

Our Focus:
biomarker discovery for complex diseases

age_associated_diseases

TAmiRNA drives R&D and contract research in liver disease, senescence, cardiovascular disease, oncology, and bone and joint disorders. Using advanced transcriptomic approaches, we aim to decode disease mechanisms, personalize diagnostics, and accelerate biomarker-driven innovations.

TAmiRNA - stability for live

biomarkers for more stability in life

Our Mission:
RNA biomarkers for precision medicine

discovery_and_validation_of_microRNA_biomarkers

TAmiRNA is dedicated to supporting researchers and clinicians in RNA biomarker discovery, validation, and development. Our mission is to provide innovative diagnostic solutions that improve patient outcomes, with a focus on precision medicine and age-associated diseases.

Our Focus:
biomarker discovery for complex diseases

mircoRNA_signatures

TAmiRNA drives R&D and contract research in liver disease, senescence, cardiovascular disease, oncology, and bone and joint disorders. Using advanced transcriptomic approaches, we aim to decode disease mechanisms, personalize diagnostics, and accelerate biomarker-driven innovations.

Our Expertise:
RNA signatures and diagnostics

We specialize in biomarker discovery using cell-free RNAs, including microRNAs, mRNAs, and long non-coding RNAs (lncRNAs). By integrating RNA signatures with AI-driven analysis, we develop actionable diagnostic solutions that enhance disease detection and patient stratification.

Services

Transcriptomic services

services

Exploring microRNAs, mRNAs, circular RNAs, or other non-coding RNAs?

TAmiRNA offers validated solutions for targeted (RT-qPCR) and untargeted (NGS-based) RNA analysis in serum, plasma, urine, saliva, milk, EVs, exosomes, cells, and tissues. With 11+ years of RNA biomarker expertise, we ensure reliable results and project success.

TAmiRNA - the power of microRNA biomarkers

RNA biomarker services

Interested in our microRNA disease panels or IVD/RUO kits but lack the time or resources for in-house analysis?

Send us your samples, and our in-house services will deliver results for hepatomiR®, senomiR®, toxomiR®, osteomiR®, and thrombomiR®. We also support custom miRNA or mRNA signature analysis by implementing tailored workflows.

TAmiRNA - the power of microRNA biomarkers
Click_here_for_your_personalized_microRNA_service_offer

our services

RNA analysis services

services

You are interested in microRNAs, mRNAs, circular RNAs, as well as other small or long non-coding RNAs?

TAmiRNA offers validated solutions for targeted (RT-qPCR) as well as untargeted (transcriptomic) analysis of any RNA in serum, plasma, urine, saliva, EVs and exosomes, cells, and tissues. Our experience of 11+ years in RNA biomarker development ensure the success of our customer projects.

TAmiRNA - the power of microRNA biomarkers

Kit services

You are interested in our microRNA disease panels or IVD/RUO kits, but don´t have the time or resources to analyse in your lab?

You can send us your samples to obtain results for hepatomiR®, senomiR®, toxomiR®, osteomiR®, or thrombomiR® by taking advantage of our in-house services. In addition, we can support the analysis of your specific miRNA or mRNA signature by implementing a tailored workflow or kit.

TAmiRNA - the power of microRNA biomarkers
TAmiRNA - stability for live

Products

TAmiRNA - stability for live
TAmiRNA - stability for live
TAmiRNA - stability for live

our products

TAmiRNA - stability for live
TAmiRNA - stability for live
TAmiRNA - stability for live

latest news

TAmiRNA CEO Dr. Matthias Hackl to Lecture on microRNA Biomarker Development at Jyväskylä Summer School 2026

By |July 31st, 2026|Categories: biomarker, circulating miRNAs, Conference, microRNA, microRNA services, miND, miND spike ins, miND spike-in, NGS, RNA, small RNA-sequencing, smallRNA|Tags: , , , , , , , , |

Our CEO Dr. Matthias Hackl, a leading expert in microRNA biomarker discovery, small RNA sequencing, and IVD development, has been invited as a lecturer at this year's Jyväskylä Summer [...]

Read More
 0

Circulating microRNAs Reveal Molecular Effect of Zoledronic Acid on Tendon-to-Bone Healing

By |July 20th, 2026|Categories: Biomarker Discovery, biomarkers, microRNA, microRNA services, microRNAs|Tags: , , , , |

New publication in the American Journal of Sports Medicine, co-authored by TAmiRNA Retears remain a common complication after arthroscopic rotator cuff repair. A recent study by researchers from the [...]

Read More
 0

Why Spike-ins Are the Key to Reproducible Small RNA-seq Data

By |June 3rd, 2026|Categories: microRNA, microRNA services, microRNAs, miND, miND spike ins, miND spike-in, NGS, small RNA-sequencing, smallRNA|Tags: , , , , |

Reproducibility is one of the biggest challenges in small RNA sequencing – and at the same time one of the most critical requirements for valid biomarker studies. Whether you [...]

Read More
Comments Off on Why Spike-ins Are the Key to Reproducible Small RNA-seq Data

TAmiRNA CEO Dr. Matthias Hackl to Lecture on microRNA Biomarker Development at Jyväskylä Summer School 2026

By |July 31st, 2026|Categories: biomarker, circulating miRNAs, Conference, microRNA, microRNA services, miND, miND spike ins, miND spike-in, NGS, RNA, small RNA-sequencing, smallRNA|Tags: , , , , , , , , |

Our CEO Dr. Matthias Hackl, a leading expert in microRNA biomarker discovery, small RNA sequencing, and IVD development, has been invited as a lecturer at this year's Jyväskylä Summer School at the [...]

Read More
 0

Circulating microRNAs Reveal Molecular Effect of Zoledronic Acid on Tendon-to-Bone Healing

By |July 20th, 2026|Categories: Biomarker Discovery, biomarkers, microRNA, microRNA services, microRNAs|Tags: , , , , |

New publication in the American Journal of Sports Medicine, co-authored by TAmiRNA Retears remain a common complication after arthroscopic rotator cuff repair. A recent study by researchers from the AUVA Trauma Center [...]

Read More
 0

Why Spike-ins Are the Key to Reproducible Small RNA-seq Data

By |June 3rd, 2026|Categories: microRNA, microRNA services, microRNAs, miND, miND spike ins, miND spike-in, NGS, small RNA-sequencing, smallRNA|Tags: , , , , |

Reproducibility is one of the biggest challenges in small RNA sequencing – and at the same time one of the most critical requirements for valid biomarker studies. Whether you are comparing data [...]

Read More
Comments Off on Why Spike-ins Are the Key to Reproducible Small RNA-seq Data
© Copyright TAmiRNA 2019 - 
Go to Top